Evaluation of Temporal Aggregation Processes Using Spatial Intensity Distribution Analysis. 2019

Zahra Rattray, and Egor Zindy, and Kara M Buzza, and Alain Pluen
Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.

Small proteinaceous oligomeric species contribute to the formation of larger aggregates, a phenomenon that is of direct relevance to the characterization of protein aggregation in biopharmaceuticals and understanding the underlying processes contributing to neurodegenerative diseases.The ability to monitor in situ oligomerization and aggregation processes renders imaging and image analysis an attractive approach for gaining a mechanistic insight into early processes contributing to the formation of larger aggregates in disease models and biologics. The combination of image analysis tools enables the detection of both oligomeric and larger aggregate subtype in contrast to conventional kinetic-based approaches that lack the ability to resolve dimers from monomeric moieties in samples containing mixed populations.In this chapter, we describe the process for confocal time series image acquisition for monitoring the in situ loss of monomers, and the subsequent analysis pipeline using spatial intensity distribution analysis (SpIDA) to evaluate oligomer content.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D001688 Biological Products Complex pharmaceutical substances, preparations, or matter derived from organisms usually obtained by biological methods or assay. Biologic,Biologic Drug,Biologic Product,Biological,Biological Drug,Biological Medicine,Biological Product,Biologics,Biopharmaceutical,Natural Product,Natural Products,Biologic Drugs,Biologic Medicines,Biologic Pharmaceuticals,Biologic Products,Biological Drugs,Biological Medicines,Biologicals,Biopharmaceuticals,Products, Biological,Drug, Biologic,Drug, Biological,Drugs, Biologic,Drugs, Biological,Medicine, Biological,Medicines, Biologic,Medicines, Biological,Pharmaceuticals, Biologic,Product, Biologic,Product, Biological,Product, Natural
D049452 Green Fluorescent Proteins Protein analogs and derivatives of the Aequorea victoria green fluorescent protein that emit light (FLUORESCENCE) when excited with ULTRAVIOLET RAYS. They are used in REPORTER GENES in doing GENETIC TECHNIQUES. Numerous mutants have been made to emit other colors or be sensitive to pH. Green Fluorescent Protein,Green-Fluorescent Protein,Green-Fluorescent Proteins,Fluorescent Protein, Green,Fluorescent Proteins, Green,Protein, Green Fluorescent,Protein, Green-Fluorescent,Proteins, Green Fluorescent,Proteins, Green-Fluorescent
D019636 Neurodegenerative Diseases Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures. Degenerative Diseases, Nervous System,Degenerative Diseases, Central Nervous System,Degenerative Diseases, Neurologic,Degenerative Diseases, Spinal Cord,Degenerative Neurologic Diseases,Degenerative Neurologic Disorders,Nervous System Degenerative Diseases,Neurodegenerative Disorders,Neurologic Degenerative Conditions,Neurologic Degenerative Diseases,Neurologic Diseases, Degenerative,Degenerative Condition, Neurologic,Degenerative Conditions, Neurologic,Degenerative Neurologic Disease,Degenerative Neurologic Disorder,Neurodegenerative Disease,Neurodegenerative Disorder,Neurologic Degenerative Condition,Neurologic Degenerative Disease,Neurologic Disease, Degenerative,Neurologic Disorder, Degenerative,Neurologic Disorders, Degenerative
D066329 Protein Aggregates Any mixture of secondary, tertiary, or quaternary protein molecules which appear as clumps in or outside the cell. Protein Aggregate,Aggregate, Protein,Aggregates, Protein

Related Publications

Zahra Rattray, and Egor Zindy, and Kara M Buzza, and Alain Pluen
April 2011, Proceedings of the National Academy of Sciences of the United States of America,
Zahra Rattray, and Egor Zindy, and Kara M Buzza, and Alain Pluen
March 2008, Journal of the Optical Society of America. A, Optics, image science, and vision,
Zahra Rattray, and Egor Zindy, and Kara M Buzza, and Alain Pluen
January 2019, Statistica Sinica,
Zahra Rattray, and Egor Zindy, and Kara M Buzza, and Alain Pluen
September 1965, Cancer research,
Zahra Rattray, and Egor Zindy, and Kara M Buzza, and Alain Pluen
February 2022, Sensors (Basel, Switzerland),
Zahra Rattray, and Egor Zindy, and Kara M Buzza, and Alain Pluen
June 1993, The Southeast Asian journal of tropical medicine and public health,
Zahra Rattray, and Egor Zindy, and Kara M Buzza, and Alain Pluen
December 1995, Biometrics,
Zahra Rattray, and Egor Zindy, and Kara M Buzza, and Alain Pluen
January 2014, IEEE transactions on pattern analysis and machine intelligence,
Zahra Rattray, and Egor Zindy, and Kara M Buzza, and Alain Pluen
January 1989, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
Zahra Rattray, and Egor Zindy, and Kara M Buzza, and Alain Pluen
July 2016, Environmental science and pollution research international,
Copied contents to your clipboard!